Willingness to participate in genomics research and desire for personal results among underrepresented minority patients: A structured interview study

Journal of Community Genetics

Volumn 4, Issue 4, 2013, Pages 469-482

  Sanderson, Saskia C ^a   Diefenbach, Michael A ^a   Zinberg, Randi ^a   Horowitz, Carol R ^a   Smirnoff, Margaret ^a   Zweig, Micol ^a   Streicher, Samantha ^b   Jabs, Ethylin Wang ^a   Richardson, Lynne D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Genomicsresearch; Interest; Interviews; Patients; Personal results

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ALTRUISM; ARTICLE; ATTITUDE TO HEALTH; BLACK; CONTROLLED STUDY; ETHNIC GROUP; ETHNICITY; FAMILY HISTORY; FEMALE; GENETIC RISK; GENETICS; HEALTH BELIEF; HISPANIC; HUMAN; INCOME; MALE; MINORITY GROUP; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARTICIPATORY RESEARCH; PATIENT PARTICIPATION; PRIORITY JOURNAL; STRUCTURED INTERVIEW; VERY ELDERLY; WHITE;

EID: 84885011052     PISSN: 1868310X     EISSN: 18686001     Source Type: Journal    
DOI: 10.1007/s12687-013-0154-0     Document Type: Article

References (60)

1. Andrykowski MA, Munn RK, Studts JL (1996) Interest in learning of personal genetic risk for cancer: a general population survey. Prev Med 25:527-536
2. Beskow LM, Burke W (2010) Offering individual genetic research results: context matters. Sci Transl Med 2:38cm20.
3. Bollinger JM, Scott J, Dvoskin R, Kaufman D (2012) Public preferences regarding the return of individual genetic research results: findings from a qualitative focus group study. Genet Med 14:451-457
4. Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, Gronberg H (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36:235-241
5. Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR (2008) Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine 87(1):1-9
6. Bray GA (2004) Medical consequences of obesity. J Clin Endocrinol Metab 89(6):2583-2589
7. Byrd GS, Edwards CL, Kelkar VA, Phillips RG, Byrd JR, Pim-Pong DS, Starks TD, Taylor AL, Mckinley RE, Li YJ, Pericak-Vance M (2011) Recruiting intergenerational African American males for biomedical research studies: a major research challenge. J Natl Med Assoc 103(6):480-487
8. Cameron LD, Sherman KA, Marteau TM, Brown PM (2009) Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol 28:307-316
9. Clayton EW, McGuire AL (2012) The legal risks of returning results of genomics research. Genet Med 14:473-477
10. Croyle RT, Lerman C (1993) Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev Med 22:284-292
11. Decruyenaere M, Evers-Kiebooms G, Denayer L, Welkenhuysen M, Claes E, Legius E, Demyttenaere K (2000) Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counseling. EJHG 8:130-136
12. Dorsey E, Darwin K, Nichols P, Kwok J, Bennet C, Rosenthal L, Bombard Y, Shoulson I, Oster E. Knowledge of the Genetic Information Nondiscrimination act among individuals affected by Huntington disease (2012). Clin Genet. [Epub ahead of print].
13. Dressler L (2012) Return of research results from pharmacogenomic versus disease susceptibility studies; what's drugs got to do with it? Pharmacogenomics 13:935-949
14. Dressler LG, Smolek S, Ponsaran R, Markey JM, Starks H, Gerson N, Lewis S, Press N, Juengst E, Wiesner GL (2012) IRB perspectives on the return of individual results from genomic research. Genet Med 14:215-222
15. Ejiogu N, Norbeck JH, Mason MA, Cromwell BC, Zonderman AB, Evans MK (2011) Recruitment and retention strategies for minority or poor clinical research participants: lessons from the Healthy Aging in Neighborhoods of Diversity across the Life Span study. Gerontol Suppl 1:S33-45
16. Farmer DF, Jackson SA, Camacho F, Hall MA (2007) Attitudes of African American and low socioeconomic status white women toward medical research. J Health Care Poor Underserved 18(1):85-99
17. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303(3):235-41
18. Ford BM, Evans JS, Stoffel EM, Balma J, Regan MM, Syngal S (2006) Factors associated with enrollment in cancer genetics research. Cancer Epidemiol Biomarkers Prev 15(7):1355-1359
19. Fullerton SM, Wolf WA, Brothers KB, Clayton EW, Crawford DC, Denny JC, Greenland P, Koenig BA, Leppig KA, Lindor NM et al (2012) Return of individual research results from genomewide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med 14:424-431
20. Gill PS, Plumridge G, Khunti K, Greenfield S (2013) Underrepresentation of minority ethnic groups in cardiovascular research: a semi-structured interview study. Fam Pract 30(2):233-241
21. Gill PS, Shankar A, Quirke T, Freemantle N (2009). Access to interpreting services in England: secondary analysis of national data. BMC Public Health 12;9:12.
22. Graves KD, Peshkin BN, Luta G, Tuong W, Schwartz MD (2011) Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Public Health Genomics 14(3):178-189
23. Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y (2013) Identifying personal genomes by surname inference. Science 339(6117):321-324
24. Haga SB (2010) Impact of limited population diversity of genome-wide association studies. Genet Med 12(2):81-84
25. Haga SB, O'Daniel JM, Tindall GM, Lipkus IR, Agans R (2012) Survey of US public attitudes toward pharmacogenetic testing. Pharmacogenomics J 12(3):197-204
26. Halverson CM, Ross LF (2012) Attitudes of African-American parents about biobank participation and return of results for themselves and their children. J Med Ethics 38(9):561-566
27. Jacobsen PB, Valdimarsdottier HB, Brown KL, Offit K (1997) Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 59:459-466
28. James RD, Yu JH, Henrikson NB, Bowen DJ, Fullerton SM, Health Disparities Working Group (2008) Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet 11(4):241-249
29. Kagawa-Singer M (2000) Improving the validity and generalizability of studies with underserved U.S. populations expanding the research paradigm. Ann Epidemiol 10(8 Suppl):S92-103
30. Kaufman D, Murphy J, Scott J, Hudson K (2008) Subjects matter: a survey of public opinions about a large genetic cohort study. Genet Med 10:331-339
31. Kollek R, Petersen I (2011) Disclosure of individual research results in clinico-genomic trials: challenges, classification and criteria for decision-making. J Med Ethics 37:271-275
32. Lemke A, Wolf W, Herbert-Beirne J, Smith M (2010) Public and biobank participant attitudes toward genetic research participation and data sharing. Public Health Genomics 13:368-377
33. Lerman C, Croyle RT, Tercyak KP, Hamann H (2002) Genetic testing: psychological aspects and implications. J Consult Clin Psychol 70(3):784-797
34. Lerman C, Daly M, Masny A, Balshem A (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12:843-850
35. Lerman C, Rimer B, Engstrom PF (1989) Reducing avoidable cancer mortality through prevention and early detection regimens. Cancer Res 49:4955-4962
36. Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF (1990) Factors associated with repeat adherence to breast-cancer screening. Prev Med 19:279-290
37. Lerman C, Seay J, Balshem A, Audrain J (1995) Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet 57:385-392
38. Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal E, Patrick-Miller L, Robitaille C (1997) Illness representations: theoretical foundations. In: Petrie KJ, Weinman JA (eds) Perceptions of health and illness. Harwood, Amsterdam, pp 19-45
39. Leventhal H, Leventhal EA, Cameron L (2001) Representations, procedures, and affect in illness self-regulation: A perceptualcognitive model. In: Baum A, Singer JE (eds) Handbook of health psychology. Erlbaum, Mahwah, pp 19-47
40. Levickis P, Naughton G, Gerner B, Gibbons K (2013) Why families choose not to participate in research: feedback from nonresponders. J Paediatr Child Health 49(1):57-62
41. Lewis J, Palmer N, Hicks P et al (2008) Association analysis in African Americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes 58:2220-2225
42. Marteau TM, Weinman J (2006) Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 62:1360-1368
43. McEwen JE, Boyer JT, Sun KY (2013). Evolving approaches to the ethical management of genomic data. Trends Genet [Epub ahead of print].
44. Meltzer LA (2006) Undesirable implications of disclosing individual genetic results to research participants. Am J Bioeth 6:28-30; author reply W10-22.
45. Misiewicz S, Winawer MR (2012) Recruitment for genetic studies of epilepsy. Epilepsy Res 101(1-2):122-128
46. Nobile H, Vermeulen E, Thys K, Bergmann MM, Borry P (2013) Why do participants enroll in population biobank studies? A systematic literature review. Expert Rev Mol Diagn 13(1):35-47
47. O'Daniel J, Haga SB (2011) Public perspectives on returning genetics and genomics research results. Public Health Genom 14:346-355
48. Ridgeway JL, Han LC, Olson JE, Lackore KA, Koenig BA, Beebe TJ, Ziegenfuss JY (2013). Potential Bias in the Bank: What Distinguishes Refusers, Nonresponders and Participants in a Clinic-Based Biobank? Public Health Genomics [Epub ahead of print].
49. Rogers RW (1983) Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In: Cacioppo J, Petty R (eds) Social psychophysiology. Guilford, New York, pp 153-176
50. Sanderson SC, Diefenbach, MA, Streicher SA, Jabs EW, Smirnoff M, Horowitz CR, Zinberg R, Clesca C, Richardson LD (2013) Genetic and lifestyle causal beliefs about obesity and associated diseases among ethnically diverse patients: a structured interview study. Public Health Genomics 16(3):83-93
51. Sanderson SC, Wardle J (2008) Associations between anticipated reactions to genetic test results and interest in genetic testing: will selfselection reduce the potential for harm? Genet Test 12(1):59-66
52. Sanderson SC, Wardle J, Jarvis MJ, Humphries SE (2004) Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Prev Med 39:458-464
53. Sanderson SC, Wardle J, Michie S (2005) The effects of a genetic information leaflet on public attitudes towards genetic testing. Public Underst Sci 14(2):213-224
54. Satia JA, McRitchie S, Kupper LL, Halbert CH (2006) Genetic testing for colon cancer among African-Americans in North Carolina. Prev Med 42(1):51-59
55. Segal ME, Polansky M, Sankar P (2007a) Predictors of uptake of obesity genetic testing among affected adults. Hum Genet 120:641-652
56. Segal ME, Polansky M, Sankar P (2007b) Adults' values and attitudes about genetic testing for obesity risk in children. Int J Pediatr Obes 2:11-21
57. Streicher SA, Sanderson SC, Jabs EW, Diefenbach M, Smirnoff M, Peter I, Horowitz CR, Brenner B, Richardson LD (2011) Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study. J Community Genet 2:153-163
58. Thompson HS, Valdimarsdottir HB, Jandorf L, Redd W (2003) Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women. Patient Educ Couns 51(3):217-227
59. Wallace SE, Kent A (2011) Population biobanks and returning individual research results: mission impossible or new directions? Hum Genet 130:393-401
60. Yang Q, Liu T, Shrader P et al (2010) Racial/ethnic differences in association of fasting glucose-associated genomic loci with fasting glucose, HOMA-B, and impaired fasting glucose in the U.S. adult population. Diabetes Care 33:2370-2377